FRM
Fox Run Management’s Altimmune ALT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-38,200
| Closed | -$191K | – | 837 |
|
|
2025
Q1 | $191K | Buy |
38,200
+25,295
| +196% | +$126K | 0.03% | 806 |
|
|
2024
Q4 | $93K | Buy |
+12,905
| New | +$93K | 0.02% | 811 |
|
|
2023
Q2 | – | Sell |
-30,435
| Closed | -$128K | – | 664 |
|
|
2023
Q1 | $128K | Buy |
+30,435
| New | +$128K | 0.04% | 586 |
|
|
2022
Q4 | – | Sell |
-12,823
| Closed | -$164K | – | 597 |
|
|
2022
Q3 | $164K | Buy |
+12,823
| New | +$164K | 0.06% | 509 |
|
|
2021
Q4 | – | Sell |
-11,165
| Closed | -$126K | – | 459 |
|
|
2021
Q3 | $126K | Buy |
+11,165
| New | +$126K | 0.08% | 411 |
|